Cite
HARVARD Citation
Coimbra, S. et al. (2022). Metabolic syndrome and cardiovascular disease risk in end-stage renal disease patients. Atherosclerosis. pp. 168-169. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Coimbra, S. et al. (2022). Metabolic syndrome and cardiovascular disease risk in end-stage renal disease patients. Atherosclerosis. pp. 168-169. [Online].